Previous close | 5.05 |
Open | 5.02 |
Bid | 5.07 x 300 |
Ask | 5.11 x 1000 |
Day's range | 5.02 - 5.16 |
52-week range | 4.71 - 12.43 |
Volume | |
Avg. volume | 2,105,667 |
Market cap | 736.106M |
Beta (5Y monthly) | 1.38 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.54 |
Earnings date | 02 May 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 11.29 |
ROCKVILLE, Md. & EDMONTON, Alberta, April 16, 2024--UPDATE: New Aurinia Presentation Details at the 2024 Bloom Burton & Co. Healthcare Investor Conference
ROCKVILLE, Md. & EDMONTON, Alberta, April 15, 2024--Aurinia Pharmaceuticals to Release First Quarter Financial and Operational Results on May 2, 2024
ROCKVILLE, Md. & EDMONTON, Alberta, April 09, 2024--Aurinia Will Attend 2024 Bloom Burton & Co. Healthcare Investor Conference